Provider of medical research and education precinct intended for the conduct of early phase clinical trials. The company is an 80-bed clinical trials facility intended for biotechnology and pharmaceutical clients, enabling an extensive experience evaluating new therapeutic treatments including vaccines and devices in both healthy volunteer and patient populations for a variety of early-stage clinical trials.